Adaptive Biotechnologies Corporation
ADPTNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $4.08B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $12.00$30.74
- Volume (live)
- -
- Avg. volume (3M)
- 2.34M
Adaptive Biotechnologies (ADPT) Stock Price & Financial Analysis
Adaptive Biotechnologies Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $23.82 - $25.62 |
|---|---|
| 52-Week High | $30.74 |
| 52-Week Low | $12.00 |
| Open | $24.23 |
| Volume (last close) | 1.91M |
| Average Volume (3M) | 2.34M |
| Revenue (TTM) | 308.08M |
|---|---|
| Net Income (TTM) | -63.85M |
| Free Cash Flow (TTM) | -24.03M |
| EPS (TTM) | −$0.40 |
| Profit Margin | -20.73% |
| Operating Margin | -12.16% |
| Return on Equity (ROE) | -42.38% |
| Debt to Equity | 2.28 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.08B |
|---|---|
| Shares Outstanding | 159.86M |
| Price to Sales (P/S) | 13.24 |
| Price to Book (P/B) | 27.07 |
| EV/EBITDA | -224.09 |
| 50-Day MA | $26.13 |
|---|---|
| 200-Day MA | $19.22 |
| 1-Year Change | +42.25% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Adaptive Biotechnologies at a Glance
As of the Oct 23, 2026 close, Adaptive Biotechnologies (ADPT) has a market capitalization of $4.08B. The stock trades at 13.2× sales. Over the trailing twelve months it lost $63.85M on revenue of $308.08M and burned $24.03M of free cash flow. Revenue grew 50.1% year over year.
As of its latest reported balance sheet, it holds $169.87M in cash and securities against $343.70M of debt, a net debt position of $173.83M.
Adaptive Biotechnologies does not currently pay a dividend.
The share price is up 42.2% over the past year. At $25.51 (the Oct 23, 2026 close) it sits within its 52-week range of $12.00 to $30.74, above its 200-day moving average of $19.22.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $30.56, 19.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Adaptive Biotechnologies
What is the current stock price for ADPT?
As of the Oct 23, 2026 close, ADPT stock trades at $25.51. The 52-week range is $12.00–$30.74, with a day range of $23.82–$25.62.
What is the P/E ratio for ADPT?
The P/E ratio (Price-to-Earnings) for ADPT is shown in the Key Statistics section. This valuation metric helps compare Adaptive Biotechnologies Corporation to industry peers.
Does ADPT pay dividends?
Adaptive Biotechnologies does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADPT?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for ADPT is Buy. The average 12-month price target is $30.56, a 19.8% upside from the Oct 23, 2026 close of $25.51.
What is the market cap of ADPT?
As of the Oct 23, 2026 close, Adaptive Biotechnologies's market capitalization is $4.08B, classifying it as a mid-cap company. Adaptive Biotechnologies operates in the Healthcare sector within the Diagnostics & Research industry.